| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |